In addition, the advantage of a vaccine containing NS-derived T cell epitopes resides in its capacity to strongly activate CD8 T cells that could prevent ADE, as shown in several animal models [61,62]. This evidence concerns the gene CD8A and acute disseminated encephalomyelitis.